Vasoactive intestinal peptide (VIP) stimulated adenylyl cyclase activity in rat and mouse peritoneal macrophage membranes. GTP potentiated the stimulatory effect of VIP so that it was routinely included at 10 IxM GTP. Other agents like GTP, Gpp(NH)p, GTP-3,-S, sodium fluoride, and forskolin, at a concentration of 0.1 mM, increased the basal activity of enzyme by 3.1, 5.7, 4.7, 3.6, and 7.8-fold, respectively. The stimulation of adenylyl cyclase by VIP was time, temperature, and membrane concentration dependent. Half-maximal enzyme activation (EDso) was very similar in rat and mouse peritoneal macrophage membranes (1.5 _+ 0.1 nM and 1.0 _+ 0.1 nM, respectively). However, VIP showed more efficacy in mouse macrophages membranes (about 3.l-fold basal values) than that in rat macrophage membranes (about 2.5-fold basal values). The relative potency of several peptides upon stimulation of adenylyl cyclase activity showed the following potency in both species: VIP = PACAP38 = PACAP27 > helodermin > PHI > secretin. On the other hand, a Mr-45 kDa ~ subunit of G~ protein was demonstrated by both ADP-ribosylation and immunoblot in mouse and rat peritoneal macrophage membranes. The present results, together other previous, strongly suggest that VIP play an important role in the regulation of macrophage function.
Introduction
Vasoactive intestinal peptide (VIP) is a 28 amino acid peptide that is produced by the central and peripheral nervous system [1] , where it is considered to behave as a neurotransmitter or a neuromodulator [1] , and by immune system [2] , where it is considered to behave as an important immunoregulatory peptide [3] . The biological effects of VIP on its target cells are triggers by the interaction of peptide with specific plasma membrane receptors coupled to the enzyme adenylyl cyclase and the subsequent cyclic AMP (cAMP) production. In this context, specific receptors for VIP have been demonstrated in human lymphocytes [4, 5] , human monocytes [6] , both mouse and rat lymphocytes [7, 8] , and more recently, in mouse and rat peritoneal macrophages [9, 10] , where it has been shown that VIP receptor is a membrane protein of 52 kDa [9, 10] and the VIP binding to its receptor is regulated by guanine nucleotides [11] . On the other hand, VIP has been shown to activate adenylyl cyclase in human lymphocyte membranes [12] and to stimulate cyclic AMP production in human lymphocytes [4, 5] and in mouse and rat peritoneal macrophages [9, 13] . Finally, VIP has been reported to activate cyclic AMP-dependent protein kinase (PKA) in human lymphocytes [14] .
At a molecular level, it is well established in the VIP signal transduction pathway that VIP receptors are coupled to the adenylyl cyclase through a stimulatory GTP binding protein G~ [15, 16] . In macrophages, though the cAMP production has been well reported, a complete functional and molecular characterization of the adenylyl cyclase activated for VIP never has been realized. The aim of the present report is to study at functional and molecular level the adenylyl cyclase activated for VIP in rat and mouse peritoneal macrophages.
Materials and methods
Synthetic rat VIP, pituitary adenylyl cyclase activating peptide (PACAP-27 and PACAP-38), porcine peptide histidine isoleucine (PHI), helodermin, secretin, and insulin were purchased from Peninsula Laboratories Europe (Merseyside, UK). Bacitracin, bovine serum albumin (BSA), 3-isobutyl-l-methyl-xanthine (IBMX), ethylenediaminetetraacetic acid (EDTA), N-[2-hydroxyethyl]piperazine-N'-[2-hydroxypropanesulfonic acid] (Hepes), forskolin, cholera toxin, GTP, guanosine 5'-[3,~/-imidotriphosphate [Gpp(NH)p], guanosine 5'-O-(3-triphosphate) (GTP-3,-S), ATP, CTP, creatine phosphokinase, and creatine phosphate were from Sigma (Alcobendas, Spain). Phenylmethylsulfonylfluoride (PMSF), N-et-tosyl-L-lysine chloromethyl ketone (TLCK) and leupeptine were from Boehringer Mannheim GmbH (Germany). Chemicals and protein markers for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were from Bio-Rad Laboratories (Richmond, CA, USA). Cyclic AMP assay kits were obtained from Radiochemical Center (Amersham, UK).
[32p]NAD was from New England Nuclear-Dupont.
Specific antisera against C-terminal (385-394) of ot~ subunit of G~ protein was from Calbiochem.
Preparation of macrophage membranes
Rat and mouse peritoneal macrophages were obtained from Wistar rats and Swiss mouse respectively as described previously [9, 10] . Quickly, macrophages were resuspended in 5 mM HEPES (pH 7.5 at 4°C) containing 0.1 mg/ml bacitracin, 0.01 mg/ml leupeptine, 0.01 mg/ml TLCK, 0.05 mg/ml PMSF, and 1 mM EDTA. After 15 min incubation at 4°C, cells were disrupted by sonication for two 10-s bursts at maximal power and tune meter separated by 10-s intervals. The homogenate was centrifugated at 600 × g for 10 min at 4°C. The 600 × g supernatant was centrifugated at 30 000 × g for 30 min at 4°C. The 30 000 × g pellet was resuspended in 20 mM Hepes (pH 7.5 at 4°C) containing 0.05 mg/ml PMSF and was immediately frozen at -80°C until used. Proteins were measured by the method of Bradford [17] using bovine serum albumin as standard.
Adenylyl cyclase assay
Adenylyl cyclase activity was measured as described previously [18] . In a standard assay, membranes (50 ixg/ml) were incubated in 0.1 ml of 25 mM triethanolamine-HC1 buffer (pH 7.5) containing 1 mM 3-isobutyl-l-methyl-xanthine (IBMX), 5 mM MgSO4, 1 mM EDTA, 1 mg/ml bacitracin, 1.5 mM ATP, 10 I~M GTP, and a ATP-regenerating system (7.4 mg/ml creatine phosphate and 1 mg/ml creatine kinase) in the absence or presence of different concentrations of VIP. After 20 min incubation at 30°C, the reaction was stopped by the addition of 2.5 ml methanol. The precipitate was removed by centrifugation, aliquots of the supernatant were evaporated and cyclic AMP was measured by a kit cyclic AMP assay system.
Cholera toxin-catalyzed ADP-ribosylation
ADP-ribosylation of membranes was carried out as previously reported [19] with minor modifications. Thiol preactivated cholera toxin was incubated at 80 ixg/mi with membranes (0.8 mg protein/ml) in 0.25 M phosphate buffer (pH 7.0) containing 5 mM ATP, 50 I~M GTP, 1
IxM [32p]NAD+, 2 mM EDTA, 5 mM MgCI2, and ATPregenerating system. After 45 min at 30°C, the reaction was stopped by ice-cold 10% (w/v) trichloroacetic acid. Protein pellets were washed with acetone and solubilized on SDS-gel loading buffer for SDS-PAGE as described [9] .
Immunodetection of ~s subunit of G~ protein
Membranes were solubilized in SDS sample buffer and proteins were run on a 10% SDS-polyacrylamide gel as described [19] . The transfer of proteins to nitrocellulose and the immunodetection of the a s of G s protein using a specific antisera against et s subunit of G s protein, were carried out as described [19] . Briefly, the transferred nitrocellulose sheets were cut into slices, preincubated with 50 mM Tris-HC1 pH 8.0, 2 mM CaC12, 80 mM NaC1, 0.2% (v/v) Nonidet P40, and 5% (w/v) non-fat dry milk. Antisera was diluted in the same buffer and incubated for 1 h at room temperature. After washing, immunoreactive protein bound was revealed using [125I]-labelled goat antibodies against rabbit IgG and immunoblots were exposed for 3 days at -80°C to a DuPont Cronex-4 film with an intensifying screen (DuPont Cronex Lightning Plus).
Results
The general characteristics of rat peritoneal macrophage membrane adenylyl cyclase are showed in Fig. 1 . The basal adenylyl cyclase activity was 9.3 _+ 0.7 pmol cAMP/min/mg protein. The GTP and its nonhydrolizable analogs Gpp(NH)p and GTP-~/-S, sodium fluoride, and forskolin stimulated the adenylyl cyclase activity in a dose-dependent manner. At a concentration of 0.1 mM, GTP, Gpp(NH)p, GTP-~/-S, sodium fluoride, and forskolin increased the basal activity of enzyme by 3.1, 5.7, 4.7, 3.6, and 7.8-fold, respectively. The corresponding concentrations required for half-maximal stimulation (EDs0) were 0.7 IxM, 0.5 IxM, 0.6 2 IxM, 1.5 IxM, and 0.6 ~M, respectively. On the other hand, other nucleotide such as CTP, was completely ineffective in modifying basal adenylyl cyclase activity when assessed at concentrations as high as 0.1-1 mM.
VIP-stimulated adenylyl cyclase activity was a time- and temperature-dependent process ( Fig. 2) The response was rapid and linear (r = 0.90) with time up to 15 min at 30°C and decreased thereafter. At 15°C, the cAMP response decreased in rate and extent, with an apparent steady state reached after 30 rain. Fig. 3 shows the effect of increasing membrane protein concentration on VIP-stimulated adenylyl cyclase. Under standard conditions, the stimulation of adenylyl cyclase activity was linear (r = 0.98) with protein concentration up to 50 Ixg protein/ml. Thus, membrane concentration of 50 Ixg protein/ml was used in subsequent experiments.
VIP-stimulated adenyly1 cyclase activity in a dose-dependent manner both in rat and mouse peritoneal macrophage membranes (Fig. 4) . The response occurred in the 0.1-1000 nM range of VIP concentrations. Maximal stimulation was obtained between 0.1-1 IxM VIP in both species. However, VIP showed more efficacy in mouse macrophages membranes (about 3.1-fold basal values) than that in rat macrophage membranes (about 2.5-fold basal values). On the other hand, the potency of VIP was very similar in rat and mouse peritoneal macrophage membranes, as indicated by the corresponding EDso values (1.5 _ 0.1 nM and 1.0 _+ 0.1 nM, respectively). The effect of VIP on adenylyl cyclase activity in rat and mouse peritoneal macrophage membranes was potentiated by GTP (Fig. 4) , since the increase in enzyme activity caused by the nucleotide plus VIP was significantly greater than the sum of the increase caused by each agent acting alone. The specificity of VIP on adenylyl cyclase activity in rat and mouse peritoneal macrophage membranes was studied using several peptides either structurally related or not to VIP (Fig. 5 and Table 1 ). The dose-effect curves for peptide stimulation of adenylyl cyclase showed the following potency in both species: VIP = PACAP38 = PACAP27 > helodermin > PHI > secretin. Under experimental con- ditions used, PACAP38, PACAP27 or helodermin did not result in a stimulation higher than that obtained with the most efficient peptide (VIP), suggesting that VIP-related peptide acted through a common membrane receptor. Other peptide not structurally related to V1P such as insulin, was ineffective on the stimulation of enzyme activity when assessed at concentrations as high as 0.1-1 IxM. It is well established that adenylyl cyclase activity is stimulated by a s subunit of stimulatory G protein (Gs). On the other hand, as it is shown in Fig, 4 , the stimulatory effect of VIP on adenylyl cyclase activity in rat and mouse peritoneal macrophage membranes was strongly potentiated by GTP. This feature indicates that the functional coupling of VIP receptors to adenylyl cyclase occurs through a G~ protein. Further experiments explored the presence of a s subunit of G~ protein in rat and mouse peritoneal macrophage membranes by ADP-ribosylation with cholera toxin and by immunoblot with a specific antisera against a s. Thus, both rat and mouse peritoneal macrophage membranes were treated with cholera toxin in the presence of [32p]NAD under conditions in which the G~ protein is specifically labelled on its a~ subunit by ADP-ribosylation. As it is shown in Fig. 6 , cholera toxin induced the labelling by 32p in the Mr-45 kDa a~ subunit in both membrane preparations. As control, no incorporation of 32p radioactivity was detected when the cholera toxin was omitted (Fig. 6 ). Immunoblot using a anti-a~ subunit antibody also revealed the Mr-45 kDa o~ subunit in both rat and mouse peritoneal macrophage membranes (Fig. 7) .
Discussion
The present study shows that VIP stimulates in a dosedependent manner the adenylyl cyclase activity in rat and mouse peritoneal macrophage membranes. Furthermore, in this report we show experimental evidence that strongly suggests that this stimulation is mediated by a G S protein.
The general characteristics of adenylyl cyclase present in rat peritoneal macrophage membranes, such as its stimulation by GTP, Gpp(NH)p, GTP-~/-S, sodium fluoride, and forskolin are in good agreement with that described in guinea pigs [20] . Maximal stimulation for VIP of the adenylyl cyclase activity was obtained between 0.1-1 ~M VIP in both species. However, VIP showed more efficacy in to activate the enzyme in mouse macrophages membranes (about 3.1-fold basal values) than that in rat macrophage membranes (about 2.5-fold basal values). On the other hand, the potency of VIP, as it is indicated by the corresponding half-maximal stimulation (EDso) values, was very similar in rat and mouse peritoneal macrophage membranes (1.5 + 0.1 nM ~md 1.0 + 0.1 nM, respectively). These results are in good agreement with the K d value of the high-affinity receptors (1.1 + 0.1 nM in rat and 1.0 + 0.2 nM in mouse) and with the EDso values for cyclic AMP accumulation (1.2 ___ 0.5 nM in rat and 1.0 ___ 0.2 nM in mouse) described previously in intact macrophages [9, 13, 21] . These data suggest that only the binding of VIP with its high-affinity receptors is coupled to the adenylyl cyclase and the subsequent cyclic AMP production. Similar results have been shown for VIP in human lymphocytes [4, 5] , rat alveolar macrophages [22] , and in other cells [23, 24] .
The effect of VIP upon adenylyl cyclase activity was strongly potentiated by GTP in rat and mouse peritoneal macrophage membranes. This result is in concordance with that observed in other VIP systems such as human lymphocytes [12] , rat intestinal membranes [25] , and rat seminal vesicle membranes [24] . This feature is other experimental result that suggests that the functional VIP receptors are coupled to adenylyl cyclase through a G~ protein. In fact, we have evidenced the presence of a ot~ subunit of 45 kDa by ADP-ribosylation with cholera toxin and by immunoblot with a specific antisera against a~ of G~ protein in both rat and mouse peritoneal macrophage membranes. This G~ protein has been showed by other authors in human lymphocytes [26, 27] , but it has never been described in rat and mouse peritoneal macrophages. On the other hand, in other tissues such as liver [25] , brain [28] , pancreas [29] , and parotid acini [30] , the GTP displayed only a slight potentiating effect on the action of VIP.
Various peptides structurally related to VIP also caused a significant stimulation of adenylyl cyclase activity in rat and mouse peritoneal macrophage membranes. The doseeffect curves for peptide stimulation of adenylyl cyclase showed the following potency in both species: VIP = PACAP38 = PACAPz7 > helodermin > PHI > secretin. Other peptide not structurally related to VIP such as insulin, was ineffective on the stimulation of adenylyl cyclase activity when assessed at concentrations as high as 0.1-1 IxM. This pattern of specificity correlates well with the specificity observed in binding and cyclic AMP accumulation studies previously reported in rat and mouse intact macrophages [9, 13, 21 ] . Under experimental conditions used, neither PACAP38, PACAP27, helodermin nor peptide structurally related to VIP, resulted in a stimulation higher than that obtained with the most efficient VIP concentration. An important and interesting feature of these results is that VIP, PACAP38, and PACAP27 caused a stimulation of adenylyl cyclase in rat and mouse peritoneal macrophage membranes with very similar potency. This datum supports the view that VIP and PACAP acted through a common membrane receptor in both species. The fact that the VIP, PACAP38 , and PACAP27 may share an identical binding site has been previously reported in rat and human liver [31, 32] , human intestine [33] , rat lung [34] , and mouse splenocytes [35] . Actually, this common receptor that shows very similar affinities for PACAP27, PACAP38, and for VIP is denominated VIP type I receptor/PACAP type II receptor and it is clearly different from the so-called PACAP type I receptor observed in rat hypothalamus or rat astrocytes [36, 37] that has a high affinity for PACAP27 and PACAP38 but a very low affinity for VIP.
At present, two types of VIP receptors have been cloned and sequenced. The type 1 receptor (VIP1-R) is the classical VIP receptor and was cloned by screening rat lung [38, 39] and the type 2 receptor (VIP2-R), that was cloned from a rat olfactory bulb cDNA library [40] , and it seems to be present in regions with neuroendocrine functions where VIP1-R is absent. On the other hand, recently has been cloned a VIP receptor from SUP-T1 lymphoblasts that has 87% sequence homology with the VIP2-R [41] . We consider that the type of VIP receptor involved in the effects showed in this paper is the VIP1-R. In fact, it has been recently shown the gene expression of VIP1-R type in both rat T and B lymphocytes [42] . Furthermore, we have shown for the first time the expression of VIP1-R type in rat peritoneal macrophages [43] .
The previous demonstration of the presence of high affinity and specificity VIP receptors in rat and mouse peritoneal macrophages [9, 10, 21] , the sensitivity of VIP binding activity to guanine nucleotides [11] , together the ability of VIP to stimulate the adenylyl cyclase activity, argue strongly for a physiological role of VIP in the regulation of macrophage function.
Macrophages play a principal role in many immune functions, but the molecular mechanisms involved are poorly defined. Many hormonally responsive systems are regulated through changes in intracellular cyclic AMP levels. It is well documented that numerous macrophage functions, including lysosomal enzyme secretion [44] , phagocytosis [45] , cytotoxicity [46] , chemotaxis [47] , and adhesion [48] are influenced by agents that modulate cyclic AMP levels. With respect to VIP and macrophages, it has been reported that VIP inhibits the respiratory burst in monocytes, the precursor cell of macrophages, and that VIP inhibits substrate adherence capacity of rat peritoneal macrophage membranes by mechanisms that involve cyclic AMP [49, 50] . In this context, our results strongly suggest that VIP could play an important role in regulation of immune function not only acting on lymphocyte functions [51] , but also modulating macrophage functions.
